Admission plasma leptin level strongly correlates with the success of thrombolytic therapy in patients with acute myocardial infarction

Angiology

Volumn 57, Issue 6, 2006, Pages 671-680

  Amasyali, Basri ^a   Aytemir, Kudret ^b   Kose, Sedat ^a   Kilic, Ayhan ^a   Abali, Gulcan ^b   Iyisoy, Atila ^a   Kursaklioglu, Hurkan ^a   Turan, Mustafa ^a   Bingol, Necati ^c   Isik, Ersoy ^a   Demirtas, Ertan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Bayindir Medical Center   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HEPARIN; LEPTIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBRINOLYTIC THERAPY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; MALE; OUTCOME ASSESSMENT; RADIOIMMUNOASSAY; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; TREATMENT OUTCOME;

FEMALE; HOSPITALIZATION; HUMANS; LEPTIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RADIOIMMUNOASSAY; STREPTOKINASE; STROKE VOLUME; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 33845714707     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706295204     Document Type: Article

References (51)

1. Eckel RH, Krauss RM, for the AHA Nutrition Committee: American Heart Association call to action: Obesity as major risk factor for coronary heart disease. Circulation 97: 2099-2100, 1998.
2. Juhan-Vague I, Alessi MC, Morange PE: Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 32: 78-84, 2000.
3. Winkler UH: Obesity and hemostasis. Arch Gynecol Obstet 261: 25-29, 1997.
4. Cusin I, Sainsbury A, Doyle P, et al: The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes 44: 1467-1470, 1995.
5. Zimmet P, Hodge A, Nicolson M, et al: Serum leptin concentration, obesity, and insulin resistance in Western Samoans: Cross-sectional study. Br Med J 313: 965-969, 1996.
6. Leyva F, Godsland IF, Ghatei M, et al: Hyperleptinemia as a component of metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18: 928-933, 1998.
7. Friedman JM, Halaas JL: Leptin and regulation of body weight in mammals. Nature 395: 763-770, 1998.
8. Söderberg S, Ahren B, Jansson JH, et al: Leptin is associated with increased risk of myocardial infarction. J Int Med 246: 409-418, 1999.
9. Bodary PF, Westrick RJ, Wickenheiser KJ, et al: Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 287: 1706-1709, 2002.
10. Konstantinides S, Schafer K, Koschnick S, et al: Leptin-dependent platelet aggregation and arterial thrombosis suggest a mechanism for atherothrombotic disease in obesity. J Clin Invest 108: 1533-1540, 2001.
11. Maruyama I, Nakata M, Yamaji K: Effect of leptin on platelet and endothelial cells. Ann NY Acad Sci 902: 315-319, 2000.
12. Söderberg S, Olsson T, Eliasson M, et al: Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Int Med 245: 533-543, 1999.
13. Lundergan CF, Reiner JS, McCarthy WF, et al: Clinical predictors of early infarct-related artery patency following thrombolytic therapy: Importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: The GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol 32: 641-647, 1998.
14. Schroder R, Dissmann R, Bruggemann T, et al: Extent of early ST-segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 24: 384-391, 1994.
15. American Society of Echocardiography Committee on Standards: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2: 358-367, 1989.
16. Killip T, Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two years experience with 250 patients. Am J Cardiol 20: 457-464, 1967.
17. Fibrinolytic Therapy Trialists (FTT) Collaborative Group: Indications for fibrinolytic therapy in suspected acute myocardial infarction. Lancet 343: 311-322, 1994.
18. Figueras J, Monasterio Y, Lidon RM, et al: Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: In-hospital course and relationship with recurrent angina at rest. J Am Coll Cardiol 36: 2036-2043, 2000.
19. Sharma SC, Seth HN: Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in acute myocardial infarction. Br Heart J 40: 526-529, 1978.
20. Van Belle E, Lablanche JM, Bauters C, et al: Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: Natural history and the effect of thrombolysis. Circulation 97: 26-33, 1998.
21. Kono T, Morita H, Nishina T, et al: Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol 27: 774-778, 1996.
22. Braunwald E: Morning resistance to thrombolytic therapy. Circulation 91: 1604-1606, 1995.
23. Goldhammer E, Kharash L, Abinader EG: Circadian fluctuations in the efficacy of thrombolysis with streptokinase. Postgrad Med J 75: 667-671, 1999.
24. Kapiotis S, Jilma B, Quehenberger P, et al: Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation 96: 19-21, 1997.
25. Grimaudo V, Hauert J, Bachmann F, et al: Diurnal variation of the fibrinolytic system. Thromb Haemost 59: 495-499, 1988.
26. Marchant B, Stevenson R, Vaishnav S, et al: Influence of the autonomic nervous system on circadian patterns of myocardial ischaemia: Comparison of stable angina with the early postinfarction period. Br Heart J 71: 329-333, 1994.
27. Ehrly AM, Jung G: Circadian rhythm of human blood viscosity. Biorheology 10: 577-583, 1973.
28. Brezinski DA, Tofler GH, Muller JE, et al: Morning increase in platelet aggregability: Association with assumption of the upright posture. Circulation 78: 35-40, 1988.
29. Willich SN, Linderer T, Wegscheider K, et al: ISAM Study Group. Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior b-adrenergic blockade. Circulation 80: 853-858, 1989.
30. Ridker PM, Manson JAE, Buring JE, et al: Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 82: 897-902, 1990.
31. Licinio J, Mantzoros C, Negrao AB, et al: Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 3: 575-579, 1997.
32. Sinha MK, Ohannesian JP, Heiman ML, et al: Nocturnal rise of leptin in lean, obese, and non-insulindependent diabetes mellitus subjects. J Clin Invest 97: 1344-1347, 1996.
33. Paolisso G, Manzella D, Montano N, et al: Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab 85: 1810-1814, 2000.
34. De Mitrio V, De Pergola G, Vettor R, et al: Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. Metabolism 48: 960-964, 1999.
35. Barbash GI, Hod H, Roth A, et al: Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. Am J Cardiol 64: 1231-1235, 1989.
36. ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 339: 753-770, 1992.
37. Volpi A, de Vita C, Franzosi MG, et al: Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravivenza nell'Infarto Miocardico (GISSI-2) Data Base. J Am Coll Cardiol 24: 608-615, 1994.
38. Kornowski R, Goldbourt U, Zion M, et al: Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group. Am J Cardiol 72: 883-888, 1993.
39. Nordt TK, Moser M, Kohler B, et al: Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction Thromb Haemost 80: 881-886, 1998.
40. Rentrop KP: Thrombi in acute coronary syndromes. Revisited and revised. Circulation 101: 1619-1626, 2000.
41. Andrews J, Straznicky IT, French JK, et al: ST-segment recovery adds to the assessment of TIMI-2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. Circulation 101: 2138-2143, 2000.
42. Matetzky S, Freimark D, Chouraqui P, et al: The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion. J Am Coll Cardiol 32: 1326-1330, 1998.
43. Santoro GM, Valenti R, Buonamici P, et al: Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 82: 932-937, 1998.
44. Van't Hof AW, Liem A, de Boer MJ, et al: Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350: 615-619, 1997.
45. Anderson JL, Karagounis LA, Califf RM: Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction. Am J Cardiol 78: 1-8, 1996.
46. Anderson JL, Karagounis LA, Becker LC, et al: TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Circulation 87: 1829-1839, 1993.
47. Biasucci LM, Liuzzo G, Angiolillo DJ, et al: Inflammation and acute coronary syndromes. Herz 25: 108-112, 2000.
48. Moreno PR, Falk E, Palacios IF, et al: Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90: 775-778, 1994.
49. Sarraf P, Frederich RC, Turner EM, et al: Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia. J Exp Med 185: 171-175, 1997.
50. Janik JE, Curti BD, Considine RV, et al: Interleukin-1-alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 82: 3084-3086, 1997.
51. Wallace AM, Sattar N, Mcmillan DC: The coordinated cytokine/hormone response to acute injury incorporates leptin. Cytokine 12: 1042-1045, 2000.